Novo Raises Forecast as Wegovy Pill Fuels Sales

drug approval expired 68% Health

Novo Nordisk A/S has raised its profit and sales forecast for the year, crediting the successful introduction of the Wegovy pill for this positive adjustment. The company anticipates smaller declines than previously expected.

🇩🇰 Location: DK — Sources: 5 — First seen: — Last seen:
Novo Nordisk Wegovy sales forecast pharmaceutical

Linked Entities

Novo Nordisk A/S

organization involved

Wegovy

organization involved 🇺🇸

Contributing Articles